CaridianBCT and Terumo Transfusion are becoming Terumo BCT, the world leader in blood component technology. 

Pueblo, Fort Collins lead economic comeback in Colorado
The Denver Post 
 

Denver Business Journal
by Greg Avery, Reporter  

Boulder, CO, January 10, 2012 – MBio Diagnostics, Inc. announced that its CEO, Christopher
Myatt, Ph.D., will present at the BioTech Showcase 2012 in San Francisco on January 11th at
9:00 a.m PST at San Francisco’s Parc 55 Wyndham hotel. Dr. Myatt will present an overview on
the Company including its accomplishments in 2011 and its focus for 2012 and the future.

About MBio:
MBio Diagnostics, Inc. (www.mbiodx.com) is a privately held clinical diagnostics and life
sciences technology company based in Boulder, CO. MBio is developing a suite of simple,
multiplexed diagnostic tests using its proprietary LightDeckTM technology. Initial product
development focuses on high impact infectious diseases, including HIV, hepatitis, and influenza.
The company’s product development is aimed at decentralized testing, from the clinic to the
home. 

FORT COLLINS, Colo., Jan. 9, 2012 St. Renatus, LLC, the northern Colorado start-up company founded to commercialize and distribute a new needle-free dental anesthetic, announced today that the company secured up to $3.5 million dollars from an angel investment group, and will move forward with Phase 3 clinical trials. 

DENVER ­— Monday, Jan. 9, 2012 — Gov. John Hickenlooper today unveiled recommendations to reduce government “red tape” and regulatory inefficiencies based on feedback from more than 100 business organizations, local governments, advocacy and community groups statewide.